Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Anthony Scott Praill currently holds 277,273 shares of Kintara Therapeutics, Inc. (KTRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Anthony Scott Praill has been a net buyer of KTRA stock. They have purchased $19.5K and sold $0 worth of shares.
Anthony Scott Praill's most recent insider trade was on Aug 1, 2022, when they sold 240,087 shares at $0.00 per share.
Anthony Scott Praill serves as Executive at Kintara Therapeutics, Inc. (KTRA). They have executed 19 insider transactions totaling $19.5K over their tenure at the company.
Anthony Scott Praill holds the position of Executive at Kintara Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Anthony Scott Praill has shown a buying trading pattern, with $19.5K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Anthony Scott Praill was on Dec 8, 2021, when they purchased $19.5K worth of KTRA shares. This transaction involved 28,700 shares at $0.68 per share.
Anthony Scott Praill currently owns 277,273 shares of Kintara Therapeutics, Inc. (KTRA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Anthony Scott Praill's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Anthony Scott Praill has 19 Form 4 filings on record as an insider at Kintara Therapeutics, Inc..
Set alerts for Anthony Scott Praill and 40,000+ other insiders.